4BMM |
Crystal structure of Trypanosoma cruzi CYP51 bound to the inhibitor (R)-N-(3-(1H-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-2',3, 5'-trifluoro-(1,1'-biphenyl)-4-carboxamide |
date |
|
authors | Choi, J.Y., Calvet, C.M., Gunatilleke, S.S., Roush, W.R., McKerrow, J.H., Podust, L.M. |
compound |
source |
symmetry | |
|
crystal cell |
length a |
length b |
length c |
angle alpha |
angle beta |
angle gamma |
|
|
|
|
|
|
|
method | X-Ray Diffraction | resolution | 2.84 |
ligand | HEM, TU1
| enzyme |
|
Gene Ontology |
Chain | Function | Process | Component | A, D, C, B |
|
|
|
|
Primary reference | 4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency., Calvet CM, Vieira DF, Choi JY, Kellar D, Cameron MD, Siqueira-Neto JL, Gut J, Johnston JB, Lin L, Khan S, McKerrow JH, Roush WR, Podust LM, J Med Chem. 2014 Aug 19. PMID:25101801 |